Compared to Estimates, Aquestive Therapeutics (AQST) Q1 Earnings: A Look at Key Metrics
AQSTAquestive(AQST) Zacks Investment Research·2024-05-08 08:01

Aquestive Therapeutics (AQST) reported 12.05millioninrevenueforthequarterendedMarch2024,representingayear−over−yearincreaseof8.312.05 million in revenue for the quarter ended March 2024, representing a year-over-year increase of 8.3%. EPS of -0.17 for the same period compares to 0.11ayearago.Thereportedrevenuerepresentsasurpriseof−1.370.11 a year ago. The reported revenue represents a surprise of -1.37% over the Zacks Consensus Estimate of 12.22 million. With the consensus EPS estimate being -$0.09, the EPS surprise was -88.89%. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectatio ...